IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease

被引:128
作者
Mu, W
Ouyang, X
Agarwal, A
Zhang, L
Long, DA
Cruz, PE
Roncal, CA
Glushakova, OY
Chiodo, VA
Atkinson, MA
Hauswirth, WW
Flotte, TR
Rodriguez-Iturbe, B
Johnson, RJ
机构
[1] Univ Florida, Div Nephrol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[3] Univ Florida, Inst Genet, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
[6] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA
[7] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[8] Univ Maracaibo, Div Nephrol, Maracaibo, Venezuela
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 12期
关键词
D O I
10.1681/ASN.2005030297
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IL-10 is a pluripotent cytokine that plays a pivotal role in the regulation of immune and inflammatory responses. Whereas short-term administration of IL-10 has shown benefit in acute glomerulonephritis, no studies have addressed the potential benefits of IL-10 in chronic renal disease. Chronically elevated blood levels of IL-10 in rats were achieved by administration of a recombinant adeno-associated virus serotype 1 IL-10 (rAAV1-IL-10) vector. Control rats were given a similar dose of rAAV1-GFP. Four weeks after injection, IL-10 levels in serum were measured by ELISA, and chronic renal disease was induced by a 5/6 nephrectomy (n = 6 in each group). Eight weeks later, rats were killed and renal tissue was obtained for RNA, protein, and immunohistochemical analysis. Serum levels of IL-10 were 12-fold greater in the rAAV1-IL-.10 group by 4 wk after rAAV1-IL-10 administration (345 +/- 169 versus 28 15 pg/ml; P = 0.001), and levels were maintained throughout the experiment. rAAV1-IL-10 treatment resulted in less proteinuria (P < 0.05), lower serum creatinine (P < 0.05), and higher creatinine clearances (P < 0.01) compared with rAAV1-GFP-treated rats. Renal interstitial infiltration was significantly attenuated by rAAV1-IL-10 administration as assessed by numbers of CD4(+), CD8(+), monocyte-macrophages (ED-1(+)) and dendritic (OX-62(+)) cells (P < 0.05), and this correlated with reductions in the renal expression of monocyte (renal monocyte chemoattractant protein-1 mRNA and protein) and T cell (RANTES mRNA) chemokines. rAAV1-IL-10 administration decreased mRNA levels of IFN-gamma and IL-2 in the kidney. The reduction in inflammatory cells was associated with a significant reduction in glomerulosclerosis and interstitial fibrosis. It is concluded that IL-10 blocks inflammation and improves renal function in this model of chronic renal disease. The feasibility of long-term overexpression of a gene using the AAV serotype 1 vector system in a model of renal disease is also demonstrated.
引用
收藏
页码:3651 / 3660
页数:10
相关论文
共 54 条
[1]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]  
2-4
[3]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[4]   Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney [J].
Choi, YK ;
Kim, YJ ;
Park, HS ;
Choi, K ;
Paik, SG ;
Lee, YI ;
Park, JG .
GENE THERAPY, 2003, 10 (07) :559-568
[5]   Recombinant adeno-associated virus vectors for gene therapy [J].
Conlon, TJ ;
Flotte, TR .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1093-1101
[6]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[7]  
DE WMR, 1991, J EXP MED, V174, P1209
[8]  
DING L, 1992, J IMMUNOL, V148, P3133
[9]   Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits [J].
Feldman, LJ ;
Aguirre, L ;
Ziol, M ;
Bridou, JP ;
Nevo, N ;
Michel, JB ;
Steg, PG .
CIRCULATION, 2000, 101 (08) :908-916
[10]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815